Jaid, Farnisa J.

HRN: 49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2022
CEFTRIAXONE 1G (VIAL)
07/13/2022
07/20/2022
IV DRIP
800mg
Q24H
PCAP, BA In AE
Waiting Final Action 
07/13/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/13/2022
07/20/2022
IV DRIP
400mg
Q6h
PCAP-D
Waiting Final Action 
07/13/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/13/2022
07/20/2022
IV
120mg
Q24H
PCAP-D
Waiting Final Action 
07/19/2022
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
07/19/2022
07/26/2022
ORAL
2.5 Ml
BID
Pcap
Waiting Final Action 
07/19/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
07/19/2022
07/23/2022
PO
2ml
OD
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: